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Xenotransplantation oﬀers a potentially unlimited source for tissues and organs for transplantation, but the strong xenoimmune
responses pose a major obstacle to its application in the clinic. In this study, we investigate the rejection of mouse peripheral nerve
xenografts in rats. Severe intragraft mononuclear cell inﬁltration, graft distension, and necrosis were detected in the recipients as
early as 2 weeks after mouse nerve xenotransplantation. The number of axons in xenografts reduced progressively and became
almost undetectable at week 8. However, mouse nerve xenotransplantation only led to a transient and moderate increase in the
production of Th1 cytokines, including IL-2, IFN-γ,a n dT N F - α. The data implicate that cellular immune responses play a critical
role in nerve xenograft rejection but that further identiﬁcation of the major eﬀector cells mediating the rejection is required for
developing eﬀective means to prevent peripheral nerve xenograft rejection.
Copyright © 2009 Lai-Jin Lu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Becauseperipheralnerve tissuehasverylimitedspontaneous
regenerative capacity, the development of strategies to facili-
tate axonal regeneration is highly important for treatment of
peripheral nerve injuries [1–3]. Although autotransplanta-
tion is considered the “gold standard” approach for bridging
nerve gaps, autogenous grafts provide only a limited source
ofgraftmaterialandgraftharvesting mayresultinsecondary
site morbidity. Allogeneic and xenogeneic nerve allografts
provide an attractive alternative for patients, for whom
the use of autograft is infeasible or undesirable. However,
immunological rejection poses a major obstacle to clinical
allogeneic and xenogeneic transplantation.
Unlike organ transplantation, in most cases peripheral
nerve injury is not life-threatening, and therefore, peripheral
nerve xenotransplantation can only be considered when
its beneﬁt is weighted against the risk associated with the
therapy, such as the side eﬀects of immunosuppressive
drugs. Peripheral nerves contain Schwann cells, ﬁbroblasts,
and extracellular matrix. Schwann cells and ﬁbroblasts both
expressMHCantigensandplayanimportantroleineliciting
immunological rejection after allogeneic nerve transplanta-
tion [4]. However, immunologic responses following nerve
xenotransplantation are relatively poorly understood. In
this study, we investigate the immunological response and
graft survival in rats after nerve xenotransplantation from
mice. We show that mouse nerve xenografts were vigor-
ously rejected in rat recipients, and that the rejection was
associated with severe intragraft inﬁltration by mononuclear
cells despite only a transient and moderate increase in Th1
cytokines detected in the recipients.
2.MaterialsandMethods
2.1. Animals. Female SD rats (weighed between 150 and
200g) and adult female BALB/c mice were used as the recip-
ients and donors, respectively. All animals were purchased
from the Second Aﬃliated Hospital of Harbin Medical
University (Haerbin, China). All surgical procedures and
postoperative care of the animals were approved by the
Institutional Animal Ethics Committee.2 Journal of Biomedicine and Biotechnology
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Figure 1:Severemononuclearcellinﬁltrationandgraftdestruction
in mouse nerve xenografts. Autologous (a)–(c) and xenogeneic
mouse (d)–(f) nerve grafts were harvested at weeks 2 (a) and (d),
4 (b) and (e), and 8 (c) and (f) posttransplantation and analyzed
by light microscopy with H&E staining. Five rats per group were
examined at each time point, and representative samples (x40) are
shown. Mononuclear cell inﬁltration was detected (arrowheads)
around nerve ﬁber bundle (NFB) in mouse nerve xenografts at all
time points examined.
2.2. Peripheral Nerve Xenotransplantation. A l ls u r g i c a lp r o -
cedures were performed under anesthesia with ketamine
(50mg/kg; i.m.). To prepare donor nerve grafts, the mouse
sciatic nerve was exposed through a dorsal gluteal muscle
splitting incision, and a segment (1cm) of sciatic nerve was
harvested and used immediately. The skin over the recipient
right hindlimb was incised, and the muscle was bluntly
dissected to expose the superﬁcial peroneal nerve, and a
1cm gap was created. The mouse sciatic nerve graft was
interposed to the transected nerve and immediately repaired
with 10-0nylon epineurial sutures. For autograft recipients,
the right superﬁcial peroneal nerve was exposed in an
identicalfashion,transectedwithmicroscissors,andtension-
free repair of the nerve gap (1cm) was then performed with
10-0nylon epineurial sutures.
2.3. ELISA. Sera were collected from recipient mice at
various times, and the levels of IL-2, IL-4, IFN-γ,a n dT N F - α
were determined using ELISA kits (Westang Biotechnology,
Shanghai, China) according to the manufacturer’s
instructions.
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Figure 2: Rapid and progressive loss of axons in mouse nerve
xenografts.Autologous(a)–(c)andxenogeneicmouse(d)–(f)nerve
grafts were harvested at weeks 2 (a) and (d), 4 (b) and (e), and
8 (c) and (f) posttransplantation and analyzed by immunohisto-
chemistry with S-100 staining. Five rats per group were examined
at each time point (these are the same animals shown in Figure 1),
and representative samples (x40) are shown. NF, nerve ﬁbers.
2.4. Histological Evaluation. Animals were sacriﬁced at var-
ious time points after transplantation, and the nerve grafts
were harvested and cut in half horizontally. One segment
was immersed in a 10% formaldehyde solution, dehydrated
in ethanol, and embedded in paraﬃn. The paraﬃnn e r v e
sections were stained with hematoxylin and eosin (H&E)
andbyimmunohistochemistryforS-100.Brieﬂy,sectionsfor
S-100 staining were ﬁrst incubated with polyclonal rabbit
anti-S-100 antibodies (Westang Biotechnology), washed,
and followed by staining with biotinylated goat antirabbit
antibodies (Westang Biotechnology). DAB Substrate was
used for colorimetric detection. Another segment of the
nerve graft was immersed in a 3% cold gluteraldehyde
solution, postﬁxed with osmium tetroxide, dehydrated in
ethanol, and embedded in Araldite 502. Ultrathin sections
were obtained with an ultramicrotome (ULTRACUT E,
Reichert-Jung, Vienna, Austria), stained with lead citrate
and uranyl acetate, and observed under a JEOL transmis-
sion electron microscope (JEM-1220; JEOL Ltd., Tokyo,
Japan).Journal of Biomedicine and Biotechnology 3
2.5. Statistical Analysis. Diﬀerences between group means
were tested using Student’s t-test by Microsoft Excel soft-
ware. A P-value of <.05 was considered to be signiﬁcant.
3. Results
Recipient rats were sacriﬁced 2, 4, and 8 weeks after
transplantation and the nerve grafts were examined macro-
scopically and histologically (n = 5p e rg r o u pa te a c ht i m e
point). All autografts showed no distension or adhesion
to the ambient tissues throughout the 8-week observation
period. However, xenografts removed at week 2 markedly
dilated and adhered to the surrounding tissues. While some
xenografts showed moderately reduced distension at week
4, graft adhesion to the ambient tissues was progressively
overwhelming in all animals during the 8-week observation
period.
Histological examination at weeks 2 and 4 revealed very
mild mononuclear cell inﬁltration with otherwise normal
peripheral nerve structure in autografts (Figures 1(a)-1(b)
and 2(a)-2(b)). However, most autografts showed signs of
Wallerian degeneration at week 8, with moderate axonal
degeneration and nerve ﬁber fractions (Figures 1(c) and
2(c)).Consistentwiththelightmicroscopicanalysis,electron
microscopy conﬁrmed the preservation of normal fascicular
structure in autografts at weeks 2 and 4 (Figures 3(a)-
3(b)), but Schwann cell cytoplasmic degeneration, chro-
matin condensation, and nuclear collapse were identiﬁed in
the autografts at week 8 (Figure 3(c)).
Graft rejection was identiﬁed in all xenografts. Severe
mononuclear cell inﬁltration, distension and necrosis were
detected in all xenografts as early as 2 weeks after trans-
plantation (Figures 1(d)–1(f)). The number of axons in
the grafts markedly reduced by week 2 and became
almost undetectable at week 8 (Figures 2(d)-2(e)). Electron
microscopy revealed inﬂammatory inﬁltrates in nerve ﬁbers,
Schwann cell nuclear pycnosis and mitochondrial damage,
and progressive destruction and loss of myelinated ﬁbers in
all xenografts (Figures 3(d)–2(f)).
Sera were collected from xenograft recipients prior to
2, 4, and 8 weeks after transplantation, and the levels of
IL-2, IL-4, IFN-γ,a n dT N F - α were determined by ELISA
(Table 1). While the serum levels of IL-2, IFN-γ,a n dT N F - α
at week 2 were statistically higher in the xenograft recipients
than in the control rats, these increases were relatively less
marked and transient. The serum levels of all these cytokines
inthexenograftrecipientsreturnedtonormalbyweek4after
transplantation.
4. Discussion
Xenotransplantation provides a possible solution to the
severeshortageofallogeneicdonorsthatlimitsclinicaltrans-
plantation [5–7], but the virulent xenoimmune responses
pose a strong barrier to clinical xenotransplantation [7].
Transplantation of discordant xenografts results in hyper-
acute rejection due to the presence of natural antibodies
(NAbs) in the recipient sera. The major NAbs that mediate
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Figure 3: Electron microscopic analysis of autologous and xeno-
geneic nerve grafts. Autologous (a)–(c) and xenogeneic mouse (d)–
(f) nerve grafts were examined at weeks 2 (a) and (d), 4 (b) and
(e), and 8 (c) and (f) posttransplantation. Five rats per group were
analyzed at each time point (these are the same animals shown
in Figure 1), and representative samples (x5,000) are shown. SC,
Schwann cell; NF: nerve ﬁbers.
hyperacute rejection are those which recognize the α1, 3Gal
antigens [8, 9]. However, anti-α1, 3Gal Abs are unlikely
to mediate the rejection of nerve xenografts, as neural
cells do not express α1, 3Gal [10]. Thus, cellular immune
responses, which play a critical role in nerve allograft
rejection [11] ,a r el i k e l yt ob em o r ei m p o r t a n tt h a nh u m o r a l
immune responses in nerve xenograft rejection. Indeed,
nerve xenograft rejection has been relatively poorly studied
compared to other cellular or organ xenografts. Here, we
observed that mouse nerve xenografts can be vigorously
rejected in rats, and the rejection is associated with a severe
mononuclear cell inﬁltration in the grafts.
Schwann cells are critical for nerve regeneration, but
also the major cells trigger the rejection of nerve allografts
because of their MHC expression. It has been reported that
cold preservation can decrease the number of Schwann cells
[12] and reduce the immunogenicity of nerve allografts
[13, 14]. Although recipient Schwann cells may migrate into
the graft and support axon regeneration, donor Schwann
cells in the graft are required for the regeneration of a long
nerve graft [15]. Given the possibility that the recipient
Schwann cells may be less eﬃcient in migrating into nerve
xenografts than into allografts, cold preservation could have4 Journal of Biomedicine and Biotechnology
Table 1: Serum levels of cytokines in xenograft recipients. Eight animals were analyzed at each time point and data are presented as mean
(±SDs).
Group IL-2 (pg/mL) IL-4 (pg/mL) INF-γ (pg/mL) TNF-α (pg/mL)
Control 15.66 ±1.26 2.04 ±0.27 12.41 ±1.11 13.81 ±3.28
Xenografted Week 2 20.04 ±1.65
∗ 1.42 ±0.17 22.74 ±2.45
∗ 24.58 ±2.53
∗
Week 4 16.14 ±1.91 1.92 ±0.24 14.53 ±2.31 5 .98 ±1.75
Week 8 13.9 ±4.25 2.18 ±0.21 2 .09 ±2.55 14.07 ±1.95
∗P <. 05 compared to controls.
an even greater limitation for preventing nerve xenograft
rejection. Although histological analysis conﬁrmed severe
mononuclear cell inﬁltration and complete nerve xenograft
rejection, the recipient rats showed only a transient and
moderate increase in Th1 cytokine production. Further
studies are needed to determine whether peripheral nerve
xenografts are less eﬃcient than other types of xenografts in
eliciting the systemic T cell immune responses. It is possible
that other eﬀector cells, such as Th17 cells, NK cells, and
macrophages, may play an important role in the rejection of
mouse nerve xenografts in rats. Previous studies have shown
that NK cells and macrophages contribute signiﬁcantly to
xenograft rejection due to the genetic incompatibility in
MHC class I [16] and CD47 [17, 18], which are needed
for inhibiting NK cell and macrophage activation, respec-
tively. Further studies are clearly needed to identify the
major eﬀector cells in the rejection of peripheral nerve
xenografts.
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